Growth Metrics

Intelligent Bio Solutions (INBS) EBITDA (2020 - 2024)

Historic EBITDA for Intelligent Bio Solutions (INBS) over the last 5 years, with Q1 2024 value amounting to -$3.1 million.

  • Intelligent Bio Solutions' EBITDA rose 5130.81% to -$3.1 million in Q1 2024 from the same period last year, while for Mar 2024 it was -$10.1 million, marking a year-over-year decrease of 95.2%. This contributed to the annual value of -$10.5 million for FY2023, which is 2353.27% down from last year.
  • Intelligent Bio Solutions' EBITDA amounted to -$3.1 million in Q1 2024, which was up 5130.81% from -$1.9 million recorded in Q4 2023.
  • Intelligent Bio Solutions' 5-year EBITDA high stood at -$65474.0 for Q4 2022, and its period low was -$6.4 million during Q1 2023.
  • For the 5-year period, Intelligent Bio Solutions' EBITDA averaged around -$2.2 million, with its median value being -$2.0 million (2022).
  • Its EBITDA has fluctuated over the past 5 years, first skyrocketed by 6060.33% in 2022, then plummeted by 280382.44% in 2023.
  • Quarter analysis of 5 years shows Intelligent Bio Solutions' EBITDA stood at -$1.1 million in 2020, then tumbled by 33.51% to -$1.5 million in 2021, then skyrocketed by 95.65% to -$65474.0 in 2022, then tumbled by 2803.82% to -$1.9 million in 2023, then tumbled by 64.67% to -$3.1 million in 2024.
  • Its EBITDA stands at -$3.1 million for Q1 2024, versus -$1.9 million for Q4 2023 and -$2.5 million for Q3 2023.